Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stroke

  Free Subscription


Articles published in Atherosclerosis

Retrieve available abstracts of 69 articles:
HTML format



Single Articles


    November 2022
  1. LI W, Luo J, Peng F, Liu R, et al
    Spatial metabolomics identifies lipid profiles of human carotid atherosclerosis.
    Atherosclerosis. 2022;364:20-28.
    PubMed     Abstract available


  2. NOSSENT AY
    The epitranscriptome: RNA modifications in vascular remodelling.
    Atherosclerosis. 2022 Nov 9:S0021-9150(22)01500.
    PubMed     Abstract available


  3. CHENG X, Ouyang F, Ma T, He L, et al
    The individual and joint associations of depression and sleep duration with cardiometabolic diseases and mortality: A prospective cohort study.
    Atherosclerosis. 2022;361:10-17.
    PubMed     Abstract available


    October 2022
  4. YUAN D, Wang P, Jia S, Zhang C, et al
    Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2022 Oct 25. pii: S0021-9150(22)01495.
    PubMed     Abstract available


  5. WETTERSTEN N, Mital R, Cushman M, Howard G, et al
    Growth hormone concentration and risk of all-cause and cardiovascular mortality: The REasons for Geographic And Racial Disparities in Stroke (REGARDS) study.
    Atherosclerosis. 2022;359:20-26.
    PubMed     Abstract available


  6. SUN Y, Zhang H, Wang B, Chen C, et al
    Joint exposure to positive affect, life satisfaction, broad depression, and neuroticism and risk of cardiovascular diseases: A prospective cohort study.
    Atherosclerosis. 2022;359:44-51.
    PubMed     Abstract available


    September 2022
  7. DE MARCHIS GM, Dittrich TD, Malik R, Zietz AV, et al
    Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.
    Atherosclerosis. 2022 Sep 26. pii: S0021-9150(22)01433.
    PubMed     Abstract available


  8. MA Y, Li S, Yang H, Zhang Y, et al
    Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults.
    Atherosclerosis. 2022;358:47-54.
    PubMed     Abstract available


    August 2022
  9. SVENDSEN K, Olsen T, Vinknes KJ, Mundal LJ, et al
    Risk of stroke in genetically verified familial hypercholesterolemia: A prospective matched cohort study.
    Atherosclerosis. 2022;358:34-40.
    PubMed     Abstract available


  10. SCHWEDHELM E, Tiedt S, Lezius S, Wolfer TA, et al
    Effective high-density lipoprotein cholesterol is associated with carotid intima-media thickness and vascular events after acute ischemic stroke.
    Atherosclerosis. 2022;357:9-13.
    PubMed     Abstract available


  11. SABA L, Antignani PL, Gupta A, Cau R, et al
    International Union of Angiology (IUA) consensus paper on imaging strategies in atherosclerotic carotid artery imaging: From basic strategies to advanced approaches.
    Atherosclerosis. 2022;354:23-40.
    PubMed     Abstract available


  12. CICERO AFG, Salvetti M
    Peripheral artery disease: A highly prevalent untreated and uncontrolled independent cardiovascular disease.
    Atherosclerosis. 2022;354:55-56.
    PubMed    


    July 2022
  13. MCKAY AJ, Gunn LH, Ray KK
    Assessing the external validity of the SAFEHEART risk prediction model in patients with familial hypercholesterolaemia in an English routine care cohort.
    Atherosclerosis. 2022 Jul 21. pii: S0021-9150(22)01352.
    PubMed     Abstract available


  14. SORTO P, Mayranpaa MI, Saksi J, Nuotio K, et al
    Glutamine synthetase in human carotid plaque macrophages associates with features of plaque vulnerability: An immunohistological study.
    Atherosclerosis. 2022;352:18-26.
    PubMed     Abstract available


    June 2022
  15. KYTO V, Saraste A, Tornio A
    Early statin use and cardiovascular outcomes after myocardial infarction: A population-based case-control study.
    Atherosclerosis. 2022;354:8-14.
    PubMed     Abstract available


  16. MARTENS LG, Luo J, Wermer MJH, Willems van Dijk K, et al
    The association between mitochondrial DNA abundance and stroke: A combination of multivariable-adjusted survival and Mendelian randomization analyses.
    Atherosclerosis. 2022;354:1-7.
    PubMed     Abstract available


    May 2022
  17. FEINSTEIN MJ, Buzkova P, Olson NC, Doyle MF, et al
    Monocyte subsets, T cell activation profiles, and stroke in men and women: The Multi-Ethnic Study of Atherosclerosis and Cardiovascular Health Study.
    Atherosclerosis. 2022;351:18-25.
    PubMed     Abstract available


  18. MATSUSHITA K, Gao Y, Sang Y, Ballew SH, et al
    Comparative mortality according to peripheral artery disease and coronary heart disease/stroke in the United States.
    Atherosclerosis. 2022 May 8. pii: S0021-9150(22)00221.
    PubMed     Abstract available


  19. KE C, Shi M, Guo D, Zhu Z, et al
    Metabolomics on vascular events and death after acute ischemic stroke: A prospective matched nested case-control study.
    Atherosclerosis. 2022;351:1-8.
    PubMed     Abstract available


  20. MATSUOKA S, Kaneko H, Okada A, Itoh H, et al
    Association of retinal atherosclerosis assessed using Keith-Wagener-Barker system with incident heart failure and other atherosclerotic cardiovascular disease: Analysis of 319,501 individuals from the general population.
    Atherosclerosis. 2022;348:68-74.
    PubMed     Abstract available


  21. BOFFA MB
    Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis.
    Atherosclerosis. 2022;349:72-81.
    PubMed     Abstract available


  22. ARSENAULT BJ, Kamstrup PR
    Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective.
    Atherosclerosis. 2022;349:7-16.
    PubMed     Abstract available


    April 2022
  23. CHO IY, Yoo JE, Han K, Kim D, et al
    Frequent drinking is more predictive of ischemic stroke than binge drinking, but not of myocardial infarction.
    Atherosclerosis. 2022;350:65-72.
    PubMed     Abstract available


  24. LUCCI C, van den Beukel TC, Bartstra JW, Zwanenburg J, et al
    Intracranial atherosclerosis in pseudoxanthoma elasticum: A case-control study.
    Atherosclerosis. 2022;350:19-24.
    PubMed     Abstract available


    March 2022
  25. KHARE HA, Dossing KBV, Ringgaard L, Christensen E, et al
    In vivo detection of urokinase-type plasminogen activator receptor (uPAR) expression in arterial atherogenesis using [(64)Cu]Cu-DOTA-AE105 positron emission tomography (PET).
    Atherosclerosis. 2022 Mar 30. pii: S0021-9150(22)00159.
    PubMed     Abstract available


  26. REN S, Hansbro PM, Srikusalanukul W, Horvat JC, et al
    Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial.
    Atherosclerosis. 2022;346:68-74.
    PubMed     Abstract available


    February 2022
  27. PASZEK E, Pociask E, Zabczyk M, Piorkowski A, et al
    Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
    Atherosclerosis. 2022 Feb 11. pii: S0021-9150(22)00078.
    PubMed     Abstract available


    January 2022
  28. SIUDUT J, Natorska J, Wypasek E, Wiewiorka L, et al
    Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe aortic stenosis.
    Atherosclerosis. 2022;344:49-56.
    PubMed     Abstract available


  29. YOSHIDA Y, Chen Z, Baudier RL, Krousel-Wood M, et al
    Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.
    Atherosclerosis. 2022;344:13-19.
    PubMed     Abstract available


  30. HE X, Dong B, Liang W, Wu Y, et al
    Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
    Atherosclerosis. 2022;344:1-6.
    PubMed     Abstract available


    October 2021
  31. HOU HQ, Xiang XL, Pan YS, Zhang QH, et al
    Baseline or 90-day fibrinogen levels and long-term outcomes after ischemic stroke or TIA: Results from the China national stroke registry .
    Atherosclerosis. 2021;337:35-41.
    PubMed     Abstract available


  32. LUIJTEN SPR, van der Donk SC, Compagne KCJ, Yo LSF, et al
    Intracranial carotid artery calcification subtype and collaterals in patients undergoing endovascular thrombectomy.
    Atherosclerosis. 2021;337:1-6.
    PubMed     Abstract available


    August 2021
  33. SATO R, Okada K, Akiyama E, Konishi M, et al
    Impact of sarcopenic obesity on long-term clinical outcomes after ST-segment elevation myocardial infarction.
    Atherosclerosis. 2021 Aug 27. pii: S0021-9150(21)01294.
    PubMed     Abstract available


  34. PENG R, Liu K, Li W, Yuan Y, et al
    Blood urea nitrogen, blood urea nitrogen to creatinine ratio and incident stroke: The Dongfeng-Tongji cohort.
    Atherosclerosis. 2021;333:1-8.
    PubMed     Abstract available


    July 2021
  35. ZHU Z, He Y, Shi M, Guo D, et al
    Plasma osteopontin levels and adverse clinical outcomes after ischemic stroke.
    Atherosclerosis. 2021;332:33-40.
    PubMed     Abstract available


  36. DE LUCA G, Debel N, Cercek M, Jensen LO, et al
    Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry.
    Atherosclerosis. 2021;332:48-54.
    PubMed     Abstract available


    June 2021
  37. PAQUETTE M, Fantino M, Bernard S, Baass A, et al
    Paternal inheritance predicts earlier cardiovascular event onset in patients with familial hypercholesterolemia.
    Atherosclerosis. 2021;329:9-13.
    PubMed     Abstract available


  38. VAN DAM-NOLEN DHK, van Dijk AC, Crombag GAJC, Lucci C, et al
    Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: The Plaque at RISK (PARISK) study.
    Atherosclerosis. 2021;329:22-29.
    PubMed     Abstract available


  39. CHO Y, Jeong Y, Seo DH, Ahn SH, et al
    Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study.
    Atherosclerosis. 2021;328:92-99.
    PubMed     Abstract available


    May 2021
  40. HONDA Y, Mok Y, Mathews L, Hof JRV, et al
    Psychosocial factors and subsequent risk of hospitalizations with peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Atherosclerosis. 2021 May 9. pii: S0021-9150(21)00223.
    PubMed     Abstract available


    April 2021
  41. BONETTI NR, Liberale L, Akhmedov A, Pasterk L, et al
    Long-term dietary supplementation with plant-derived omega-3 fatty acid improves outcome in experimental ischemic stroke.
    Atherosclerosis. 2021;325:89-98.
    PubMed     Abstract available


  42. METHORST R, Pasterkamp G, van der Laan SW
    Exploring the causal inference of shear stress associated DNA methylation in carotid plaque on cardiovascular risk.
    Atherosclerosis. 2021;325:30-37.
    PubMed     Abstract available


  43. TSUNEYOSHI S, Matsukuma Y, Kawai Y, Hiyamuta H, et al
    Association between geriatric nutritional risk index and stroke risk in hemodialysis patients: 10-Years outcome of the Q-Cohort study.
    Atherosclerosis. 2021;323:30-36.
    PubMed     Abstract available


    March 2021
  44. ZHANG JF, Meng X, Jing J, Pan Y, et al
    Serum calcium and long-term outcome after ischemic stroke: Results from the China National stroke registry III.
    Atherosclerosis. 2021;325:24-29.
    PubMed     Abstract available


  45. SHI F, Sun L, Kaptoge S
    Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis.
    Atherosclerosis. 2021;320:70-78.
    PubMed     Abstract available


    February 2021
  46. KISANUKI K, Muraki I, Yamagishi K, Kokubo Y, et al
    Weight change during middle age and risk of stroke and coronary heart disease: The Japan Public Health Center-based Prospective Study.
    Atherosclerosis. 2021;322:67-73.
    PubMed     Abstract available


  47. XU M, Chen R, Liu L, Liu X, et al
    Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study.
    Atherosclerosis. 2021;323:20-29.
    PubMed     Abstract available


  48. KEDHI E, Verdoia M, Suryapranata H, Damen S, et al
    Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
    Atherosclerosis. 2021;321:39-44.
    PubMed     Abstract available


    January 2021
  49. XIAO J, Padrick MM, Jiang T, Xia S, et al
    Acute ischemic stroke versus transient ischemic attack: Differential plaque morphological features in symptomatic intracranial atherosclerotic lesions.
    Atherosclerosis. 2021;319:72-78.
    PubMed     Abstract available


  50. MANTELLA LE, Liblik K, Johri AM
    Vascular imaging of atherosclerosis: Strengths and weaknesses.
    Atherosclerosis. 2021;319:42-50.
    PubMed     Abstract available


  51. LI HQ, Wang X, Wang HF, Zhang W, et al
    Dose-response relationship between blood pressure and intracranial atherosclerotic stenosis.
    Atherosclerosis. 2021;317:36-40.
    PubMed     Abstract available


  52. HUANG YC, Chang CC, Yeh CC, Lin CS, et al
    The protective effect of statins against pressure ulcers in stroke patients: A propensity-score matched study based on a real-world database.
    Atherosclerosis. 2021;317:22-28.
    PubMed     Abstract available


    December 2020
  53. ZDANYTE M, Wrazidlo RW, Kaltenbach S, Groga-Bada P, et al
    Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores.
    Atherosclerosis. 2020;318:1-7.
    PubMed     Abstract available


    November 2020
  54. PENSON PE, Banach M
    Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes.
    Atherosclerosis. 2020;316:58-65.
    PubMed     Abstract available


  55. KAUW F, de Jong PA, Takx RAP, de Jong HWAM, et al
    Effect of intravenous thrombolysis in stroke depends on pattern of intracranial internal carotid artery calcification.
    Atherosclerosis. 2020;316:8-14.
    PubMed     Abstract available


  56. KEDHI E, Delewi R, Fabris E, De Luca G, et al
    Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials.
    Atherosclerosis. 2020;315:55-61.
    PubMed     Abstract available


    October 2020
  57. BELL S, Gibson JT, Harshfield EL, Markus HS, et al
    Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study.
    Atherosclerosis. 2020;313:111-117.
    PubMed     Abstract available


    September 2020
  58. RENU A, Blasco J, Laredo C, Llull L, et al
    Carotid stent occlusion after emergent stenting in acute ischemic stroke: Incidence, predictors and clinical relevance.
    Atherosclerosis. 2020;313:8-13.
    PubMed     Abstract available


  59. LIU X, Wu S, Song Q, Wang X, et al
    Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study.
    Atherosclerosis. 2020 Sep 9. pii: S0021-9150(20)30493.
    PubMed     Abstract available


    March 2020
  60. YAO Y, Zhu H, Zhu L, Fang Z, et al
    A comprehensive contribution of genetic variations of the insulin-like growth factor 1 signalling pathway to stroke susceptibility.
    Atherosclerosis. 2020;296:59-65.
    PubMed     Abstract available


  61. MAZIDI M, Katsiki N, Mikhailidis DP, Banach M, et al
    Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies.
    Atherosclerosis. 2020;296:49-58.
    PubMed     Abstract available


  62. ADINOLFI LE, Petta S, Fracanzani AL, Coppola C, et al
    Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study.
    Atherosclerosis. 2020;296:40-47.
    PubMed     Abstract available


  63. SIMONETTO C, Heier M, Rospleszcz S, Meisinger C, et al
    Risk for cardiovascular events responds nonlinearly to carotid intima-media thickness in the KORA F4 study.
    Atherosclerosis. 2020;296:32-39.
    PubMed     Abstract available


  64. WANG A, Dai L, Zhang N, Lin J, et al
    Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA.
    Atherosclerosis. 2020;297:74-80.
    PubMed     Abstract available


  65. LIM SS, Yang YL, Chen SC, Wu CH, et al
    Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
    Atherosclerosis. 2020;297:40-46.
    PubMed     Abstract available


  66. THEN C, Then HL, Lechner A, Thorand B, et al
    Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study.
    Atherosclerosis. 2020;297:1-7.
    PubMed     Abstract available


    February 2020
  67. HSIEH CY, Lee CH, Sung SF
    Development of a novel score to predict newly diagnosed atrial fibrillation after ischemic stroke: The CHASE-LESS score.
    Atherosclerosis. 2020;295:1-7.
    PubMed     Abstract available


    January 2020
  68. CHARACH G, Karniel E, Novikov I, Galin L, et al
    Reduced bile acid excretion is an independent risk factor for stroke and mortality: A prospective follow-up study.
    Atherosclerosis. 2020;293:79-85.
    PubMed     Abstract available


  69. MUNOZ-TORRERO JFS, Zamorano J, Rico-Martin S, Rivas MD, et al
    Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
    Atherosclerosis. 2020;292:84-89.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: